Thrombectomy procedures allow surgeons to use a mechanical device to break up or remove the blood clot and restore normal blood flow. It helps neurosurgeons to improve patients’ health, especially those experiencing a large artery stroke. Thrombectomy is widely used in developed economies, due to high number of stroke incidences and increased spending in healthcare.


Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/2254


Market Dynamics

Increasing incidences of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke are the major factors fuelling high demand for thrombectomy devices. Pulmonary embolism (PE) is the most serious and life-threating complication caused due to thromboembolism. Inappropriate treatment of acute DVT can result in thrombus organization and post-thrombosis syndrome (PTS) in patients, seriously affecting their quality of life. According to University of California, about 10-15% of stroke patients are candidates for thrombectomy, and about 4.7% of patients underwent the treatment in 2015, up from 1.5% in 2009.

Despite high demand and applicability of thrombectomy devices, it also poses certain limitations, which can restrain growth of the market during the forecast period. For instance, side effects of thrombectomy include intracerebral hemorrhage, subarachnoid hemorrhage, device related injury to the vessel wall, and fragmentation of the target thrombus.


Increasing incidences of stroke worldwide is expected to drive growth of the thrombectomy devices market

According to the National Institute for Health and Care Excellence (NICE) 2018 report, the risk of stroke increases with age and the chances of getting stroke is higher in men and Asian people. Thrombectomy treatment provides an alternative in the absence of access to standard of care such as thrombolysis, which is contraindicated during pregnancy.

Rising demand for minimally invasive procedures coupled with increased patient population of stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE) are expected to drive growth of the thrombectomy devices market during the forecast period. According to WHO 2018 report, stroke is the second most common cause of death in the world, with 6.7 million stroke-related deaths each year. Moreover, the burden of disease caused by stroke is set to double worldwide, by 2030.


Thrombectomy Devices Market - Regional Insights


On the basis of region, the global thrombectomy devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe thrombectomy devices market is expected to generate significant revenue share during the forecast period, owing to increasing number of stroke cases coupled with rising geriatric population. According to the Lancet journal 2013 report, stroke affects 152,000 people annually in the U.K., which is equal to 1 person every 3 minutes and 27 seconds. According to the Health Information and Quality Authority 2017 report, in Ireland, circulatory system related diseases such as stroke and coronary hearth diseases were most common cause of death, accounting for one in three of all deaths in 2014.

Asia Pacific thrombectomy devices market is expected to expand at the highest CAGR, owing to increasing patient population base and rising disposable income among regional people. According to the National Center for Biotechnology Information (NCBI) 2013 report, in India, the incidence of stroke is about 119-145/100,000 population each year. According to a study in the Lancet journal, heart disease, and stroke in India increased by over 50% from 1990 to 2016. The severities of stroke and mortality rate were higher among women.


Thrombectomy Devices Market - Competitive Landscape


Key players operating in the global thrombectomy devices market include Applied Medical, Argon Medical Devices, Inc., Boston Scientific Corporation, BTG International, Capture Vascular, Claret Medical, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., Minnetronix, Inc., Nexgen Medical Systems, Inc., Natec Medical Ltd., Penumbra, Inc., Phenox GmbH, Stentys SA, Spectranetics Corporation, Straub Medical AG, Stryker Corporation, Terumo Corporation, and Teleflex Incorporated.


Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/2254


Thrombectomy Devices Market Restraints


High cost of thrombectomy devices eventually increases its procedure cost, which is a major setback for surgery adoption. According to NICE, July 2018 data, the cost of mechanical thrombectomy devices ranges between US$ 700 to US$ 1,719 for aspiration catheters and US$ 1,911 to US$ 6,372 for stent retrievers per unit excluding taxes. Furthermore, other side effects of thrombectomy devices include bleeding from the area where the catheter is inserted, and appearance of bruise in the area causing pain. Moreover, with the breakdown of blood clots, chemicals are released, which can temporarily affect kidney function or rarely the heart.


Detailed Segmentation:

Global Thrombectomy Devices Market, By Product Type:

Mechanical Thrombectomy Devices

Aspiration Thrombectomy Devices

Hydrodynamic Thrombectomy Devices

Ultrasonic Thrombectomy Devices

Global Thrombectomy Devices Market, By Application:

Neurovascular

Cardiovascular

Peripheral Vascular

Global Thrombectomy Devices Market, By End User:

Hospitals

Ambulatory Surgical Centers

Research Laboratories and Academic Institutes


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]